Yoram Mor Selected Research

Yoram Mor Research Topics

Disease

11	Neoplasms (Cancer) 04/2021 - 02/2005
3	Wilms Tumor (Wilm's Tumor) 01/2018 - 10/2005
3	Hemorrhage 04/2009 - 08/2002
3	Fistula 11/2006 - 02/2002
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018 - 12/2014
2	Ureteral Obstruction 07/2015 - 09/2003
2	Prostatic Neoplasms (Prostate Cancer) 02/2007 - 10/2005
2	Pain (Aches) 10/2005 - 07/2005
2	Chylous Ascites 02/2002 - 02/2002
1	Surgical Wound 09/2017
1	Urinary Tract Infections (Urinary Tract Infection) 09/2017
1	Acute Kidney Injury (Acute Renal Failure) 07/2015
1	Carcinoma (Carcinomatosis) 03/2015
1	Fibroma (Fibromatosis) 03/2015
1	Hypospadias 06/2012
1	Erectile Dysfunction 03/2010
1	Hemophilia A (Haemophilia) 09/2009
1	Thrombosis (Thrombus) 09/2009
1	Lithiasis 04/2009
1	Cholangitis 04/2009
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 10/2007
1	Nocturnal Enuresis (Bedwetting) 10/2007
1	Necrosis 02/2007
1	Stress Urinary Incontinence 11/2006
1	Prolapse 09/2006
1	Azoospermia 07/2006
1	Cystic Fibrosis (Mucoviscidosis) 07/2006
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2006
1	Hepatocellular Carcinoma (Hepatoma) 10/2005
1	Intraoperative Complications 07/2005
1	Solitary Kidney 07/2005
1	Wound Infection (Wound Infections) 06/2005
1	Pyelonephritis 03/2005
1	Residual Neoplasm 02/2005
1	Transitional Cell Carcinoma 10/2003
1	Renal Insufficiency (Renal Failure) 09/2003
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 08/2002
1	Hematuria 08/2002

Drug/Important Bio-Agent (IBA)

2	Coloring Agents (Dyes)IBA 01/2018 - 12/2014
2	halofuginoneIBA 02/2007 - 10/2005
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2002 - 02/2002
1	NeodymiumIBA 04/2021
1	HolmiumIBA 04/2021
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2017
1	AminoglycosidesIBA 09/2017
1	Cephalosporins (Cephalosporin Antibiotics)IBA 09/2017
1	CreatinineIBA 07/2015
1	recombinant FVIIa (rFVIIa)FDA Link 09/2009
1	Thrombin FDA Link 09/2009
1	Factor VIIa (Activated Factor VII)IBA 09/2009
1	osteoblast cadherinIBA 08/2009
1	Surface Antigens (Surface Antigen)IBA 08/2009
1	Methylphenidate (Ritalin)FDA LinkGeneric 10/2007
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 10/2007
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 10/2007
1	Imipramine (Janimine)FDA LinkGeneric 10/2007
1	oxybutynin (Tavor)FDA LinkGeneric 10/2007
1	Collagen Type I (Type I Collagen)IBA 02/2007
1	Docetaxel (Taxotere)FDA Link 02/2007
1	Dactinomycin (Actinomycin)FDA LinkGeneric 02/2007
1	transgelinIBA 02/2007
1	Vincristine (Oncovin)FDA LinkGeneric 02/2007
1	CytoglobinIBA 02/2007
1	Contrast MediaIBA 09/2006
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 07/2006
1	Follicle Stimulating Hormone (Follitropin)FDA Link 07/2006
1	OligonucleotidesIBA 06/2006
1	Midazolam (Versed)FDA LinkGeneric 10/2005
1	Nitrous Oxide (Laughing Gas)IBA 10/2005
1	Radioisotopes (Radionuclides)IBA 03/2005
1	Acetic Acid (Vinegar)FDA LinkGeneric 03/2005
1	PENTAIBA 03/2005
1	ParaffinIBA 02/2005
1	Complementary DNA (cDNA)IBA 10/2003
1	Heparin (Liquaemin)FDA LinkGeneric 08/2002
1	AnticoagulantsIBA 08/2002

Therapy/Procedure

5	Nephrectomy 01/2018 - 02/2002
3	Prostatectomy (Retropubic Prostatectomy) 09/2017 - 08/2002
3	Therapeutics 10/2007 - 02/2002
2	Catheters 09/2017 - 08/2002
2	Operative Time 08/2005 - 07/2005
2	Total Parenteral Nutrition 02/2002 - 02/2002
1	Lasers (Laser) 04/2021
1	Stents 08/2019
1	Radiotherapy 08/2019
1	Nephrotomy 08/2019
1	Cystectomy 03/2015
1	Surgical Flaps 06/2012
1	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 04/2009
1	Choledochostomy 04/2009
1	Solid-State Lasers 04/2009
1	Drug Therapy (Chemotherapy) 02/2007
1	Suburethral Slings (Tension-Free Vaginal Tape) 11/2006
1	Kidney Transplantation 07/2005
1	Nephroureterectomy 07/2005
1	Surgical Amputation (Amputations) 06/2005
1	Replantation 09/2003
1	Injections 08/2002
1	Transurethral Resection of Prostate (TURP) 08/2002